Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Heart Institute of Japan Candesartan Randomized trial for Evaluation in Coronary Artery Disease

Next Previous
Trial Profile

The Heart Institute of Japan Candesartan Randomized trial for Evaluation in Coronary Artery Disease

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Oct 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Candesartan cilexetil (Primary) ; Antihypertensives
  • Indications Cardiovascular disorders; Coronary artery disease; Essential hypertension; Hypertension
  • Focus Therapeutic Use
  • Acronyms HIJ-CREATE

    • Most Recent Events

    • 01 Sep 2020 Results of this post-hoc analysis presented at the ESC Congress 2020 - Annual Congress of the European Society of Cardiology
    • 31 May 2020 Results of post-hoc analysis assessing impact of age on clinical outcomes of antihypertensive therapy in patients with hypertension and CAD, published in the Journal of Clinical Hypertension (Greenwich).
    • 20 Nov 2013 Results of an analysis in patients with chronic kidney disease presented at the 86th Annual Scientific Sessions of the American Heart Association.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top